Skip to content

Comparison of the effect of intravenous catheter washing with Heparin, Normal saline, and Taurolock solution on phlebitis severity

Comparison of the effect of intravenous catheter washing with Heparin, Normal saline, and Taurolock solution on phlebitis severity

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151228025732N56
Enrollment
80
Registered
2020-10-20
Start date
2020-09-22
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thrombophlebitis. Phlebitis and thrombophlebitis

Interventions

Intervention 1: Intervention group 1: In the first group (washing the catheter with heparin solution)
Diluted heparin solution at a concentration of 100 units / ml is injected every 8 hours in a volume of 12 units with an insulin syringe into intravenous catheters (angiocatheter) and lasts up to 72 ho
Normal saline 0.9% sterile infusion for infusion is injected every 8 hours in a volume of 12 units with an insulin syringe into intravenous catheters (angiocatheter) and lasts up to 72 hours. Interven
Trolidine citrate solution (brand name Tarolak) with a volume of 12 units (insulin syringe) is injected every 8 hours into intravenous lines (angiocatheter) and lasts up to 72 hours. Intervention 4: C

Sponsors

Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Absence of vascular disorders The patient should be alert and have proper communication Healthy feeling of pain No wounds or trauma to an organ with an intravenous catheter

Exclusion criteria

Exclusion criteria: Patients with heparin allergy History of coagulation disorders and warfarin tablets Contraindications to heparin and tarolac

Design outcomes

Primary

MeasureTime frame
Phlebitis. Timepoint: 24, 48, and 72 hours after intervention. Method of measurement: Phlebitis Jackson Observation Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza Asgari

Semnan University of Medical Sciences

asgari5000@gmail.com+98 23 3345 1336

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026